BioMarin Pharmaceutical Inc. (LON:0HNC)
London
· Delayed Price · Currency is GBP · Price in USD 57.59
-0.28 (-0.48%)
At close: May 23, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 8.18 billion as of May 27, 2025. Its market cap has decreased by -34.25% in one year.
Market Cap
8.18B
Enterprise Value
7.68B
Revenue
2.28B
Ranking
n/a
PE Ratio
20.17
Stock Price
57.59
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 283.77M to 8.18B, an increase of 2,781.61%. That is a compound annual growth rate of 13.88%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.82B |
| GSK plc | 57.83B |
| Haleon | 37.07B |
| Smith & Nephew | 9.30B |
| ConvaTec Group | 5.83B |
| Hikma Pharmaceuticals | 4.58B |
| HUTCHMED (China) | 1.78B |
| Genus | 1.33B |